This presentation illustrates how action or inaction on the part of the physician led to allegations of professional liability, and how risk management techniques may have either prevented the outcome or increased the physician's defensibility. The case has been modified to protect the privacy of the physician and the patient.
Other content in this Stream
CDC Guidelines for Prescribing Opioids
In 2016, the Centers for Disease Control and Prevention (CDC) introduced guidelines for prescribing opioids to chronic pain patients.
New-to-Practice Reporter 2018
Managing opioids: claims analysis and case study; Wernicke’s encephalopathy after bariatric surgery; How to dismiss without abandoning: Ending the physician-patient relationship; Addressing transgende
Recap: “How to Fight the Opioid Epidemic”
For this year’s spring CME seminars, attorney Brett B. Rowe presented “How to Fight the Opioid Epidemic” in Austin and Houston. Here’s a brief recap with five risk management takeaways for physicians.
The Reporter Quarter 4 2017
Terminating the patient-physician relationship (2-hour CME); Managing opioids: PIAA claims analysis; Addressing transgender health care disparities; TMLT 2017 scholarship winning essay
Law Requires Texas Physicians to Query PMP Before Prescribing Opioids
Texas physicians will soon be required to check the Texas Prescription Monitoring database before prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.
Texas Medical Liability Trust (TMLT)
Our next CME seminars are in Houston and Austin this May. The topic is "How to Fight the Opioid Epidemic." Visit our CME site for details and registration. https://tmlt.inreachce.com/
TMLT
The average defense costs for #internalmedicine #opioid-related medical malpractice claims were $60,619. Read more at https://t.co/O8DWYWJ6l5, pages 16-19.
TMLT
Average defense costs for #familymedicine #opioid-related medmal claims were $45,874. Read more at https://t.co/O8DWYWJ6l5, pages 16-19.
FDA Requires Changes to Labeling for Opioid Cough and Cold Medicines
The FDA is requiring safety labeling changes to limit the use of prescription cough and cold medicines containing opioids in patients younger than 18 years old.
HIPAA and the Opioid Crisis
On October 27, the HHS Office for Civil Rights issued guidance on how HIPAA allows information sharing to respond to the opioid crisis.
The Reporter Quarter 3 2017
Preparing for a deposition; Prescribing issues: Opioids and off-label medications (CME); Overprescribing NSAIDS; Failure to diagnose; Failure to correctly prescribe and instruct in taking medication
The Reporter Volume 6 2011
Diagnostic errors; Pain management — clinical and legal perspectives (2.5-hour CME)
The Reporter March-April 2002